Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital

INTRODUCTION: Infections are a leading cause of morbidity and mortality in patients with multiple myeloma. The epidemiology, risk factors and outcomes of viral respiratory tract infections (vRTI) are not well described in patients with multiple myeloma managed with novel agents, the current standard...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Support Care Cancer
Päätekijät: Teh, Benjamin W., Worth, Leon J., Harrison, Simon J., Thursky, Karin A., Slavin, Monica A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2014
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087950/
https://ncbi.nlm.nih.gov/pubmed/25487843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2550-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia